Clinical Trial Update: Galantamine Augmentation of Escitalopram for Treatment of Depression [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating galantamine augmentation of escitalopram for depression was terminated. The update does not provide results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)
• Galantamine (galantamine)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Depression | Phase 4 | Status: TERMINATED